Instructions for Reviewers
Cellular and Molecular Biology (CMB) relies on independent expert peer review to ensure the scientific quality, ethical integrity, originality, clarity, and relevance of manuscripts submitted to the journal. Reviewers are invited to provide objective, constructive, evidence-based assessments that help editors make fair decisions and help authors improve their work.
Reviewers should accept an invitation only when they have appropriate expertise, sufficient time, and no conflict of interest that could affect their judgment.
1. Role of Reviewers
Reviewers advise the editorial office; the final editorial decision is made by the Editor-in-Chief or the assigned handling editor. Reviewers are expected to assess whether the manuscript is scientifically sound, ethically compliant, within the journal scope, clearly presented, and supported by appropriate evidence.
- Evaluate the manuscript objectively and independently.
- Identify strengths, weaknesses, methodological concerns, ethical concerns, and possible improvements.
- Provide clear comments for the authors and, where needed, confidential comments for the editor.
- Avoid personal criticism and maintain a professional, respectful tone.
- Avoid recommending acceptance, revision, or rejection based on personal preference, institutional affiliation, nationality, gender, seniority, or reputation of the authors.
2. Confidentiality of Peer Review
All manuscripts, supplementary files, reviewer reports, editorial correspondence, and data shared during peer review are confidential. Reviewers must not share, copy, distribute, cite, discuss, or use unpublished material from a submitted manuscript for personal, professional, or competitive advantage.
- Do not disclose the manuscript or review process to colleagues, students, collaborators, or third parties without prior permission from the editorial office.
- Do not contact the authors directly during or after the review process.
- Do not use unpublished data, methods, images, text, or ideas from the manuscript before publication.
- If specialist input is needed from another person, request permission from the editorial office before involving them. Any person who contributes to the review must be identified to the journal.
3. Conflicts of Interest
Reviewers must decline the invitation or inform the editorial office immediately if they have any conflict of interest that could affect, or be perceived to affect, their impartiality.
Potential conflicts include, but are not limited to:
- Recent, current, or planned collaboration with any author.
- Employment, institutional, supervisory, mentoring, or close personal relationship with any author.
- Direct competition, financial interest, intellectual property interest, or professional rivalry related to the work.
- Having reviewed the same manuscript for another journal or having prior knowledge of the submission that compromises impartiality.
If a potential conflict is uncertain, reviewers should disclose it to the editorial office and allow the editor to decide whether they may proceed.
4. Reviewer Timelines
Reviewers should respond promptly to invitations and submit their review within the agreed deadline. If more time is needed, reviewers should contact the editorial office as early as possible. If reviewers cannot complete the review, they should decline the invitation promptly and may suggest alternative qualified reviewers, provided that suggested reviewers have no conflicts of interest.
5. Scope and Editorial Suitability
CMB publishes research that provides mechanistic insight into cellular and molecular processes. Reviewers should assess whether the manuscript fits the journal scope and whether it offers a meaningful contribution to cellular biology, molecular biology, molecular microbiology, functional genomics, RNA biology, cell signaling, cell death, organelles, trafficking, cytoskeleton, stem cells, organoids, host-pathogen interactions, systems biology, computational biology with biological validation, or advanced molecular/cellular methodologies.
Manuscripts that are primarily descriptive, purely clinical without molecular or cellular insight, unrelated to cellular or molecular mechanisms, or outside the declared scope should be identified clearly in the review report.
6. Key Evaluation Criteria
|
Criterion |
Reviewer assessment points |
|
Scope fit |
Is the manuscript clearly within the journal scope? Does it provide cellular or molecular insight? |
|
Originality and significance |
Does the work add new knowledge? Is the contribution meaningful for the field? |
|
Study design and methodology |
Are the experimental design, controls, sample size, statistical methods, and analytical procedures appropriate? |
|
Data quality and reproducibility |
Are the results adequately supported by data? Are methods described in sufficient detail for replication? |
|
Figures and tables |
Are figures and tables clear, necessary, accurate, and free from inappropriate manipulation? |
|
Interpretation of results |
Are conclusions justified by the results? Are limitations acknowledged? |
|
Ethical compliance |
Are ethics approval, consent, animal welfare, trial registration, data availability, and conflict of interest statements provided where applicable? |
|
References and citation integrity |
Are references relevant, balanced, and accurate? Are there signs of citation padding, irrelevant references, excessive self-citation, or citation manipulation? |
|
Language and presentation |
Is the manuscript understandable, logically structured, and written with sufficient scientific clarity? |
7. Methodological and Statistical Assessment
Reviewers should examine whether the methodology is appropriate for the research question and whether the conclusions are supported by the data. Particular attention should be given to controls, replication, randomization, blinding, sample size justification, statistical tests, multiple comparison correction, inclusion/exclusion criteria, validation experiments, and robustness of computational or bioinformatics analyses.
- For experimental studies: assess controls, replicates, reagents, cell lines, antibodies, primers, validation procedures, and reproducibility details.
- For omics or high-throughput studies: assess data processing, quality control, batch effects, validation, repository deposition, and biological interpretation.
- For computational studies: assess algorithmic transparency, code availability where possible, benchmark datasets, validation, and biological relevance.
- For review articles: assess coverage of the literature, balance, accuracy, structure, citation relevance, and whether the article provides critical synthesis rather than simple description.
8. Research Ethics and Integrity Concerns
Reviewers should alert the editor confidentially if they identify or suspect ethical or integrity concerns. Reviewers should provide specific evidence or examples when possible, without making unsupported accusations in comments to authors.
Concerns may include:
- Plagiarism, text recycling, duplicate submission, or redundant publication.
- Fabricated, falsified, selectively reported, or manipulated data.
- Inappropriate image manipulation, duplicated image panels, or unexplained figure similarities.
- Missing or inadequate ethics approval, informed consent, animal welfare approval, biosafety approval, or clinical trial registration.
- Unclear authorship, ghost authorship, guest authorship, or undisclosed writing assistance.
- Undisclosed conflicts of interest or funding sources.
- Signs of paper-mill activity, including template-like writing, inconsistent methods, irrelevant citations, unavailable raw data, implausible author expertise, or mismatched study elements.
9. References and Citation Ethics
Reviewers play an important role in protecting citation integrity. References should be scientifically relevant, accurate, and directly connected to the manuscript. Reviewers should identify irrelevant references, citation padding, inappropriate citation clusters, excessive self-citation, or references that do not support the statements for which they are cited.
Reviewers must not request citations to their own work, to the journal, to editors, or to specific authors unless the citation is scientifically necessary and directly relevant. Any suggested citation should be justified by its relevance to the manuscript.
If references appear unrelated to the topic, inserted to manipulate citation metrics, or used to support claims they do not substantiate, reviewers should explain this in the report and provide examples.
10. Reporting Guidelines and Transparency
Reviewers should check whether the manuscript follows appropriate reporting standards where applicable. Missing reporting details should be identified in the review report.
- CONSORT for randomized clinical trials.
- PRISMA for systematic reviews and meta-analyses.
- STROBE for observational studies.
- ARRIVE for animal studies.
- CARE for case reports, when relevant.
- Field-specific standards for omics, imaging, computational biology, cell line authentication, antibody validation, and other specialized methods.
11. Use of AI-Assisted Tools by Reviewers
Because submitted manuscripts are confidential, reviewers must not upload manuscript files, figures, tables, data, or unpublished content to public or third-party AI tools unless the editorial office has explicitly permitted this and confidentiality, privacy, and data protection are guaranteed.
If AI-assisted tools are permitted and used for language support, summarization, or technical assistance, reviewers remain fully responsible for the accuracy, confidentiality, fairness, and originality of their review. AI tools must not replace the reviewer’s expert judgment. Any permitted AI use that materially contributes to the review should be disclosed to the editorial office.
12. Structure of the Review Report
A useful review report should be structured, specific, and actionable. Reviewers are encouraged to organize their comments as follows:
- Brief summary of the manuscript: summarize the objective, approach, and main findings in two or three sentences.
- Overall assessment: state the main strengths and the main weaknesses.
- Major comments: identify issues that affect validity, interpretation, novelty, ethics, scope fit, or reproducibility.
- Minor comments: identify issues related to clarity, presentation, terminology, formatting, or minor corrections.
- Citation and reference assessment: comment on whether references are relevant, balanced, and free from inappropriate citations.
- Confidential comments to the editor: raise ethical concerns, conflicts, suspected misconduct, or sensitive issues that should not be written directly to authors.
13. Tone and Constructive Feedback
Reviewer comments should be professional, respectful, and focused on the manuscript. Reviewers should avoid personal remarks, dismissive language, sarcasm, discriminatory comments, or unnecessarily harsh phrasing. Comments should help authors understand what must be improved and why.
When recommending additional experiments, analyses, or references, reviewers should explain why they are necessary for the validity, interpretation, or completeness of the manuscript.
14. Recommendation Categories
Reviewer recommendations are advisory. The editor makes the final decision after considering all reviewer reports, editorial assessment, journal scope, ethical compliance, and manuscript quality.
|
Recommendation |
When to use |
|
Accept |
The manuscript is scientifically sound, clearly presented, ethically compliant, and requires no substantive changes. |
|
Minor revision |
The manuscript is potentially acceptable after limited changes that do not affect the core validity of the study. |
|
Major revision |
The manuscript has merit but requires substantial clarification, additional analyses, stronger validation, or major restructuring before it can be reconsidered. |
|
Reject and resubmit |
The work may be suitable in principle but requires extensive new work or fundamental redesign before a new evaluation would be meaningful. |
|
Reject |
The manuscript is outside scope, lacks sufficient novelty or scientific validity, has serious methodological flaws, unsupported conclusions, inadequate ethical compliance, or integrity concerns. |
15. Revised Manuscripts
When reviewing a revised manuscript, reviewers should assess whether the authors have adequately addressed previous comments, provided a clear point-by-point response, revised the manuscript transparently, and supplied additional data or clarification where requested. Reviewers should focus primarily on unresolved major issues and avoid introducing new requirements unless they are necessary and arise from the revision.
16. Confidential Comments to the Editor
Confidential comments should be used for information that is relevant to the editorial decision but should not be shared with authors, including conflicts of interest, suspected misconduct, plagiarism, image concerns, paper-mill indicators, serious ethical concerns, or doubts about reviewer suitability. The confidential section should not contradict the public comments to authors without explanation.
17. Reviewer Recognition
CMB values the contribution of peer reviewers. Reviewer identities are treated as confidential unless a different arrangement has been explicitly approved by the journal. Reviewers may request confirmation of completed reviews for professional records when permitted by journal policy, but they must not disclose confidential manuscript details.
18. Reviewer Checklist
Before submitting the review, reviewers should verify the following points:
- I have no undisclosed conflict of interest.
- I have treated the manuscript and all review materials as confidential.
- I have assessed the manuscript’s fit with the CMB aims and scope.
- I have evaluated novelty, scientific significance, methodology, statistics, and data interpretation.
- I have checked whether ethical statements, funding, conflicts of interest, data availability, and trial registration are provided where applicable.
- I have commented on citation relevance and identified any inappropriate, irrelevant, or manipulative citations if present.
- I have separated major comments from minor comments.
- I have used respectful, evidence-based, and constructive language.
- I have placed sensitive ethical or misconduct concerns only in the confidential comments to the editor.
- My recommendation is consistent with the substance of my report.